Search

Your search keyword '"Abdou, Aly"' showing total 48 results

Search Constraints

Start Over You searched for: Author "Abdou, Aly" Remove constraint Author: "Abdou, Aly" Database Academic Search Index Remove constraint Database: Academic Search Index
48 results on '"Abdou, Aly"'

Search Results

1. Two New Mononuclear Mn(II) and Cu(II) Mixed‐Ligand Complexes Incorporating 2,6‐Di(1H‐pyrazol‐1‐yl)pyridine and 2‐Hydroxy Naphthaldehyde‐Derived Schiff Base: Structural, Theoretical, and Phenoxazinone Synthase Mimicking Activity.

2. DFT, In Vitro Antimicrobial, HCV, HBV, HAV, and Breast Cancer Molecular Docking Exploration of 6-[(E)-(4-Hydroxy-2,5-dinitrophenyl)diazenyl]-2H-chromen-2-one and 6-[(E)-(10-Hydroxy-9-anthryl)diazenyl]-2H-chromen-2-one.

3. Synthesis and in Silico Investigation of Organoselenium-Clubbed Schiff Bases as Potential M pro Inhibitors for the SARS-CoV-2 Replication.

4. Synthesis, structural elucidation, and density functional theory investigation of new mononuclear Fe(III), Ni(II), and Cu(II) mixed‐ligand complexes: Biological and catalase mimicking activity exploration.

5. Design, synthesis, structural inspection, and DFT calculation of some novel imine ciprofloxacin metal chelates: A novel approach for pharmaceutical applications and DNA interaction.

6. Lower rim thiacalixarenes derivatives incorporating multiple coordinating carbonyl groups: Synthesis, characterization, ion-responsive ability and DFT computational analysis.

7. Synthesis, Characterization, Modeling, and Antimicrobial Activity of FeIII, CoII, NiII, CuII, and ZnII Complexes Based on Tri‐substituted Imidazole Ligand.

8. An operationally simple, one‐pot, convenient synthesis, and in vitro anti‐inflammatory activity of some new spirotriazolotriazine derivatives.

9. Seven metal-based bi-dentate NO azocoumarine complexes: Synthesis, physicochemical properties, DFT calculations, drug-likeness, in vitro antimicrobial screening and molecular docking analysis.

10. Synthesis, Structural, Molecular Docking, DFT, Vibrational Spectroscopy, HOMO-LUMO, MEP Exploration, antibacterial and antifungal activity of new Fe(III), Co(II) and Ni(II) hetero-ligand complexes.

11. Fabrication, Preparation, Physicochemical Characterization, and Theoretical Studies of Some Novel Schiff Base Ciprofloxacin Metal Complexes: DNA Interaction and Biomedical Applications.

12. Innovation of some novel complexes based on 1‐(4‐nitrophenyl)‐1H‐1,2,3‐triazol‐4‐yl)methanol ligand: Synthesis, structural elucidation DFT calculation and pharmaceutical studies.

13. Design and DFT calculations of optoelectronic material based on thiazolobenzimidazole-coupled isatin derivatives.

14. Exploring the molecular structure and in vitro biological potential of newly synthesized Fe(III), Co(II), and Ni(II) coordination compounds with 2-(pyridin-2-yl)-1H-benzimidazole and phenylalanine ligands.

15. NEW Fe(III), Co(II), Ni(II), Cu(II), AND Zn(II) MIXED-LIGAND COMPLEXES: STRACTURAL, DFT, BIOLOGICAL, AND MOLECULAR DOCKING STUDIES.

16. THREE Co(II), Ni(II) AND Cu(II) SCHIFF BASE COMPLEXES INCORPORATING 2-[(4-{[(4-METHYLPHENYL)SULFONOTHIOYL]OXY}PHENYL)METHYLENE] AMINO}BENZOIC ACID: SYNTHESIS, STRUCTURAL, DFT, BIOLOGICAL AND MOLECULAR DOCKING INVESTIGATION.

17. NEW IRON(III), COBALT(II), NICKEL(II), COPPER(II), ZINC(II) MIXED-LIGAND COMPLEXES: SYNTHESIS, STRUCTURAL, DFT, MOLECULAR DOCKING AND ANTIMICROBIAL ANALYSIS.

18. Antibacterial, antifungal, anti‐inflammatory evaluation, molecular docking, and density functional theory exploration of 2‐(1H‐benzimidazol‐2‐yl)guanidine mixed‐ligand complexes: Synthesis and characterization.

19. Innovation, structural inspection for new mixed complexes: DNA binding, biomedical applications and molecular docking approaches.

20. Development of new 2-(Benzothiazol-2-ylimino)-2,3-dihydro-1H-imidazol-4-ol complexes as a robust catalysts for synthesis of thiazole 6-carbonitrile derivatives supported by DFT studies.

21. Efficiency and development of guanidine chelate catalysts for rapid and green synthesis of 7‐amino‐4,5‐dihydro‐tetrazolo[1,5‐a]pyrimidine‐6‐carbonitrile derivatives supported by density functional theory (DFT) studies

22. Comparison of the binding energies of approved mpox drugs and phytochemicals through molecular docking, molecular dynamics simulation, and ADMET studies: An in silico approach.

23. Synthesis of New Organoselenium-Based Succinanilic and Maleanilic Derivatives and In Silico Studies as Possible SARS-CoV-2 Main Protease Inhibitors.

24. New mixed‐ligand thioether‐quinoline complexes of nickel(II), cobalt(II), and copper(II): Synthesis, structural elucidation, density functional theory, antimicrobial activity, and molecular docking exploration.

25. A novel colorimetric chemosensor based on 2-[(carbamothioylhydrazono) methyl]phenyl 4-methylbenzenesulfonate (CHMPMBS) for the detection of Cu(II) in aqueous medium.

26. Design, Synthesis, Spectroscopic Inspection, DFT and Molecular Docking Study of Metal Chelates Incorporating Azo Dye Ligand for Biological Evaluation.

27. Synthesis, DFT, Biological and Molecular Docking Analysis of Novel Manganese(II), Iron(III), Cobalt(II), Nickel(II), and Copper(II) Chelate Complexes Ligated by 1-(4-Nitrophenylazo)-2-naphthol.

28. New Benzimidazole‐Based Fe (III) and Cr (III) Complexes: Characterization, Bioactivity Screening, and Theoretical Implementations Using DFT and Molecular Docking Analysis.

29. Fabrication, physicochemical characterization and theoretical studies of some new mixed ligands complexes based on N-(1H-benzimidazol-2-yl)-guanidine and 1, 10-phenanthroline: DNA interaction, biological applications and molecular docking approach.

30. Two new Cr(III) (C1) and Fe(III) (C2) complexes incorporating 2,6-pyridinedicarboxylic acid (PDC) and 2-methyl-1H-benzimidazole (MB): Synthesis, structure, DFT and phenoxazinone synthase mimicking activity.

31. Design, synthesis of new mixed azo-hydroxyquinoline complexes; in vitro anti-inflammatory, antifungal, antibacterial, theoretical, and molecular docking interactions Investigation.

32. Synthesis, characterization, molecular docking, and antimicrobial activities of some new sulfur containing norfloxacin analogues.

33. New mononuclear Fe(III), Co(II), Ni(II), Cu(II), and Zn(II) complexes incorporating 4‐{[(2 hydroxyphenyl)imino]methyl}phenyl‐4‐methylbenzenesulfonate (HL): Synthesis, characterization, theoretical, anti‐inflammatory, and molecular docking investigation

34. Designing, DFT, biological, & molecular docking analysis of new Iron(III) & copper(II) complexes incorporating 1-{[-(2-Hydroxyphenyl)methylene]amino}−5,5-diphenylimidazolidine-2,4-dione (PHNS).

35. Synthesis, characterization, DFT, biological activity evaluation, and molecular docking analysis of new 8-[(2-hydroxynaphthalen-1-yl)diazenyl]naphthalene-1,3-disulfonic acid based complexes.

36. Fe(III), Ni(II), and Cu(II)-moxifloxacin-tri-substituted imidazole mixed ligand complexes: Synthesis, structural, DFT, biological, and protein-binding analysis.

37. Fabrication, structural elucidation of some new metal chelates based on N-(1H-Benzoimidazol-2-yl)-guanidine ligand: DNA interaction, pharmaceutical studies and molecular docking approach.

38. Synthesis, spectral studies, DFT, biological evaluation, molecular docking and dyeing performance of 1-(4-((2-amino-5-methoxy)diazenyl)phenyl) ethanone complexes with some metallic ions.

39. Synthesis, Characterization, DFT, Biological and Molecular Docking of Mixed Ligand Complexes of Ni(II), Co(II), and Cu(II) Based on Ciprofloxacin and 2-(1H-benzimidazol-2-yl)phenol.

40. Designing, characterization, biological, DFT, and molecular docking analysis for new FeAZD, NiAZD, and CuAZD complexes incorporating 1-(2-hydroxyphenylazo)− 2-naphthol (H2AZD).

41. Ni(II), Pd(II) and Pt(II) complexes with SNO-group thiosemicarbazone and DMSO: Synthesis, characterization, DFT, molecular docking and cytotoxicity.

42. Synthesis, physicochemical properties, biological, molecular docking and DFT investigation of Fe(III), Co(II), Ni(II), Cu(II) and Zn(II) complexes of the 4-[(5-oxo-4,5-dihydro-1,3-thiazol-2-yl)hydrazono]methyl}phenyl 4-methylbenzenesulfonate Schiff-base ligand

43. Synthesis, structural, DFT, antibacterial, antifungal, anti-inflammatory, and molecular docking analysis of new VO(II), Fe(III), Mn(II), Zn(II), and Ag(I) complexes based on 4-((2-hydroxy-1-naphthyl)azo) benzenesulfonamide.

44. Fabrication, structural elucidation, theoretical, TD-DFT, vibrational calculation and molecular docking studies of some novel adenine imine chelates for biomedical applications.

45. Synthesis, characterization, and DFT study of linear and non-linear optical properties of some novel thieno[2,3-b]thiophene azo dye derivatives.

46. Ni(II) mixed-ligand chelates based on 2-hydroxy-1-naphthaldehyde as antimicrobial agents: Synthesis, characterization, and molecular modeling.

47. Synthesis, characterization, molecular modeling and preliminary biochemical evaluation of new copper (II) mixed-ligand complexes.

48. Design and synthesis of three Fe(III) mixed-ligand complexes: Exploration of their biological and phenoxazinone synthase-like activities.

Catalog

Books, media, physical & digital resources